To this end, we took advantage of a newly discovered point mutation (PI3KδE1021K) that constitutively activates PI3Kδ independently of upstream BCR signalling and was recently described in patients with immunodeficiency and impaired CSR20, 21. The gene discussed is BCR; the disease is immunodeficiency disease.